US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jan 17, 2025 (2 years ago)

Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations: Product intended for quarantine was inadvertently distributed.

What was recalled

Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01

Recalling firm
McKesson
NDC code
0069-0809-01
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0213-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Infliximab recalls

See all